GSM5550653 - GEO Accession Viewer

NCBI Logo GEO Logo
  • GEO Publications
    • Handout
    • NAR 2024 (latest)
    • NAR 2002 (original)
    • All publications
  • FAQ
  • MIAME
  • Email GEO
NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
 GEO help: Mouse over screen elements for information.
Scope: Self Platform Samples Series Family Format: HTML SOFT MINiML Amount: Brief Quick GEO accession: Go
Sample GSM5550653 Query DataSets for GSM5550653
Status Public on Dec 31, 2021
Title Subject ID: B0428; Tissue: nasal
Sample type RNA
Source name nasal
Organism Homo sapiens
Characteristics subject id: B0428tissue: nasalgender: Femaleage: 48status1: COVIDstatus2: Non_Hospitalizedseverity_sampling: Mildfinal_severity: Mild
Extracted molecule total RNA
Extraction protocol RNA was isolated using PAXgene blood miRNA extraction kit (Qiagen) following manufacturer recommendations and carrying out the on-column DNase I treatment during the extraction process. RNA from saliva and nasal epithelium specimens was isolated using 500ul of sample and the RNeasy microkit (Qiagen). We used Oragene RNA neutralizer solution (DNA Genotek) to precipitate impurities and inhibitors and slightly modified the protocol provided by the extraction kit as recommended by the Oragene tubes supplier
Label n/a
Label protocol n/a
Hybridization protocol We used the standard gene expression protocol for 12x RNA hybridization with 5ul of RNA as input, a hybridization time of 18h for all samples and mixing control and COVID-19 samples to avoid technical sample bias.
Scan protocol SPRINT nCounter machine
Data processing Normalization of the gene expression data was carried out for each tissue separately by selecting the optimal number and best reference candidate from the set of housekeeping (HK) genes included in the panel, as well as other endogenous genes that showed high levels of stability between samples. We excluded HK candidate genes with less than 50 raw counts in any of the samples compared from the reference selection analysis. Data normalization was performed through a combined approach using both DESeq2 and RUVSeq as described in Bhattacharya et al. (2021) (https://academic.oup.com/bib/article-abstract/22/3/bbaa163/5891144). Genes with counts below the background (mean + 2 standard deviations (SD) of the negative control spikes in the code set) were not included in the differential expression (DE) analysis. After data normalization and background thresholding, we eliminated lower expressed genes from the list.
Submission date Aug 31, 2021
Last update date Dec 31, 2021
Contact name Alberto Gómez-Carballa
E-mail(s) [email protected]
Organization name GENVIP research group
Department Pediatrics
Street address Choupana sn
City Santiago de Compostela
State/province A coruña
ZIP/Postal code 15706
Country Spain
Platform ID GPL30569
Series (1)
GSE183071 A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity
Data table header descriptions
ID_REF
VALUE normalized data
Data table
ID_REF VALUE
ABCB1 5.27683957932139
ABCF1 8.22706315896516
ABL1 8.56027654781435
ADA 5.81518350543964
AHR 11.3048764217984
AICDA
AIRE
ALAS1 9.19834817863007
APP 11.4340857770308
ARG1 5.49987855693273
ARG2 7.41788622007267
ARHGDIB 9.19162206644683
ATG10 6.80957334147214
ATG12 6.33366295674504
ATG16L1 8.05216063080339
ATG5 9.50974452521969
ATG7 8.81498994529263
ATM 5.074980903275
B2M 16.6584369192528
B3GAT1
Total number of rows: 594Table truncated, full table size 12 Kbytes.
Supplementary file Size Download File type/resource
GSM5550653_B0428-nasal.RCC.gz 6.8 Kb (ftp)(http) RCC
Processed data included within Sample table
| NLM | NIH | GEO Help | Disclaimer | Accessibility |